GROARC India Closes Trading Window Ahead of FY26 Results

OTHER
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
GROARC India Closes Trading Window Ahead of FY26 Results
Overview

GROARC Industries India has closed its trading window for designated employees and relatives starting April 1, 2026. This is a standard step before announcing audited financial results for the fiscal year ending March 31, 2026. The company's board will meet by May 30, 2026, to approve the results, after which the window will reopen.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

GROARC Industries India Closes Trading Window Ahead of FY26 Results

GROARC Industries India Limited has announced the closure of its trading window for designated persons, effective April 1, 2026. This is a standard step before the company announces its audited financial results for the fiscal year ending March 31, 2026. The company's board is scheduled to meet on or before May 30, 2026, to approve these results, after which the trading window will reopen.

The company officially notified the Bombay Stock Exchange (BSE) of this closure, which is required by SEBI regulations. It applies to designated employees and their immediate family members, preventing them from trading the company's securities. This measure is designed to prevent insider trading and ensure all investors receive material information simultaneously, promoting fair markets.

GROARC Industries India Limited, incorporated in 1992 and based in Chennai, has evolved its business focus over the years. While currently classified under "Real estate activities on a fee or contract basis," it has also been involved in IT services and food product trading. As of March 2026, its authorized share capital stands at ₹25 crore and paid-up capital at ₹20.5 crore. For the fiscal year ending March 31, 2025, GROARC reported ₹35.4 crore in revenue and maintains a nearly debt-free balance sheet. Unaudited standalone results for the quarter ended December 31, 2025, showed revenue of ₹0.92 crore and a net profit of ₹0.82 crore.

The company's filing did not mention any specific risks associated with this procedural event.

Comparing GROARC Industries India Limited directly with peers is challenging due to its varied business activities. While it operates in real estate, it has past ties to IT and food trading. Some peer lists include IT firms like IKF Technologies Limited and Infronics Systems India Limited, but a precise sector comparison remains complex given GROARC's diverse profile and market standing.

Key Financial Metrics

  • For the financial year ending March 31, 2025, GROARC Industries India Limited reported consolidated revenue of ₹35.4 crore.
  • In the quarter ended December 31, 2025, the company recorded a standalone net profit of ₹0.82 crore.

Investors will closely monitor the release of GROARC Industries India Limited's audited financial results for the fiscal year ended March 31, 2026, expected after the board meeting by May 30, 2026. Management's commentary and guidance accompanying the results will be important for understanding future prospects. Any shifts in the company's business classification or strategic direction will also be significant.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.